Community pharmacists’ adoption of medicines reclassified from prescription-only status

A systematic review of factors associated with decision making

Vibhu Paudyal, Denise Hansford, Scott Cunningham, Derek Stewart

Research output: Contribution to journalLiterature review

8 Citations (Scopus)

Abstract

Purpose
Subsequent to reclassification of legal status, more than 90 prescription-only medicines have become available in the UK alone without a prescription. Similar changes are taking place internationally. The aim was to systematically review studies reporting factors associated with community pharmacists' decision making around adoption of these reclassified medicines into practice.
Method
A systematic review of English language peer-reviewed published literature from 1990 to 2010 was conducted. Literature was identified through MEDLINE, EMBASE, IPA, CINAHL, BSP, Cochrane Library and PsychINFO databases and other sources including key conference abstracts.
Results
A total of 38 studies were included. Twenty-eight factors associated with pharmacists' decision making were identified. Medicine safety was consistently shown to be one of the key factors; however, the importance of evidence base and financial benefits of reclassification were less obvious. A paucity of high-quality studies limits generalisation of findings.
Conclusions
Patient safety appears to be the key to pharmacists' decision making. However, the study quality limitations indicate the need for further robust research. The 28 factors identified in this systematic review from international literature can aid rigorous research instrument development for future evaluations.
Original languageEnglish
Pages (from-to)396-406
Number of pages11
JournalPharmacoepidemiology and Drug Safety
Volume21
Issue number4
Early online date23 Feb 2012
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Pharmacists
Prescriptions
Decision Making
Safety
Jurisprudence
Research
MEDLINE
Libraries
Language
Medicine
Databases

Keywords

  • adoption
  • decision making
  • community pharmacists
  • reclassified medicines

Cite this

Community pharmacists’ adoption of medicines reclassified from prescription-only status : A systematic review of factors associated with decision making. / Paudyal, Vibhu; Hansford, Denise ; Cunningham, Scott ; Stewart, Derek .

In: Pharmacoepidemiology and Drug Safety, Vol. 21, No. 4, 04.2012, p. 396-406.

Research output: Contribution to journalLiterature review

@article{9bf5ed37087d4474805a51158babde5f,
title = "Community pharmacists’ adoption of medicines reclassified from prescription-only status: A systematic review of factors associated with decision making",
abstract = "Purpose Subsequent to reclassification of legal status, more than 90 prescription-only medicines have become available in the UK alone without a prescription. Similar changes are taking place internationally. The aim was to systematically review studies reporting factors associated with community pharmacists' decision making around adoption of these reclassified medicines into practice. Method A systematic review of English language peer-reviewed published literature from 1990 to 2010 was conducted. Literature was identified through MEDLINE, EMBASE, IPA, CINAHL, BSP, Cochrane Library and PsychINFO databases and other sources including key conference abstracts. Results A total of 38 studies were included. Twenty-eight factors associated with pharmacists' decision making were identified. Medicine safety was consistently shown to be one of the key factors; however, the importance of evidence base and financial benefits of reclassification were less obvious. A paucity of high-quality studies limits generalisation of findings. Conclusions Patient safety appears to be the key to pharmacists' decision making. However, the study quality limitations indicate the need for further robust research. The 28 factors identified in this systematic review from international literature can aid rigorous research instrument development for future evaluations.",
keywords = "adoption, decision making, community pharmacists, reclassified medicines",
author = "Vibhu Paudyal and Denise Hansford and Scott Cunningham and Derek Stewart",
year = "2012",
month = "4",
doi = "10.1002/pds.3219",
language = "English",
volume = "21",
pages = "396--406",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Community pharmacists’ adoption of medicines reclassified from prescription-only status

T2 - A systematic review of factors associated with decision making

AU - Paudyal, Vibhu

AU - Hansford, Denise

AU - Cunningham, Scott

AU - Stewart, Derek

PY - 2012/4

Y1 - 2012/4

N2 - Purpose Subsequent to reclassification of legal status, more than 90 prescription-only medicines have become available in the UK alone without a prescription. Similar changes are taking place internationally. The aim was to systematically review studies reporting factors associated with community pharmacists' decision making around adoption of these reclassified medicines into practice. Method A systematic review of English language peer-reviewed published literature from 1990 to 2010 was conducted. Literature was identified through MEDLINE, EMBASE, IPA, CINAHL, BSP, Cochrane Library and PsychINFO databases and other sources including key conference abstracts. Results A total of 38 studies were included. Twenty-eight factors associated with pharmacists' decision making were identified. Medicine safety was consistently shown to be one of the key factors; however, the importance of evidence base and financial benefits of reclassification were less obvious. A paucity of high-quality studies limits generalisation of findings. Conclusions Patient safety appears to be the key to pharmacists' decision making. However, the study quality limitations indicate the need for further robust research. The 28 factors identified in this systematic review from international literature can aid rigorous research instrument development for future evaluations.

AB - Purpose Subsequent to reclassification of legal status, more than 90 prescription-only medicines have become available in the UK alone without a prescription. Similar changes are taking place internationally. The aim was to systematically review studies reporting factors associated with community pharmacists' decision making around adoption of these reclassified medicines into practice. Method A systematic review of English language peer-reviewed published literature from 1990 to 2010 was conducted. Literature was identified through MEDLINE, EMBASE, IPA, CINAHL, BSP, Cochrane Library and PsychINFO databases and other sources including key conference abstracts. Results A total of 38 studies were included. Twenty-eight factors associated with pharmacists' decision making were identified. Medicine safety was consistently shown to be one of the key factors; however, the importance of evidence base and financial benefits of reclassification were less obvious. A paucity of high-quality studies limits generalisation of findings. Conclusions Patient safety appears to be the key to pharmacists' decision making. However, the study quality limitations indicate the need for further robust research. The 28 factors identified in this systematic review from international literature can aid rigorous research instrument development for future evaluations.

KW - adoption

KW - decision making

KW - community pharmacists

KW - reclassified medicines

U2 - 10.1002/pds.3219

DO - 10.1002/pds.3219

M3 - Literature review

VL - 21

SP - 396

EP - 406

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 4

ER -